Oncolytic virotherapy depends on how a virus spreads through tumour tissue, how the immune system responds, and how treatment is scheduled. I present three studies of these questions: the existence and minimum speed of travelling waves in a reaction–diffusion model of virotherapy; stacked travelling waves when an immune response is added, in which the immune response follows the viral front and can clear the virus; and an optimisation of treatment schedules, alone and combined with CAR-T cells. I conclude with ongoing work on CAR-T cell exhaustion and the conditions for tumour clearance or regrowth.